Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN001118 | 58.0420 | 14.19 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 58.0422 | 14.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 69.0576 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 73.0503 | 0.68 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 73.0892 | 23.38 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 73.0893 | 23.12 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 73.0895 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 76.0031 | 2.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 82.0786 | 2.14 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 83.9527 | 0.56 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 85.0894 | 1.5 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 89.9697 | 0.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 90.0450 | 20.66 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 92.0478 | 5.24 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 98.0367 | 12.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 99.1051 | 2.14 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 100.0158 | 1.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 101.0472 | 1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 102.0163 | 2.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 103.0454 | 1.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 103.0994 | 22.29 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 103.0995 | 21.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 103.0995 | 21.77 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 103.0995 | 22.48 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 103.0996 | 22.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 103.0998 | 22.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 104.0077 | 1.16 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 104.0612 | 16.33 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 105.0413 | 0.71 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 105.9434 | 0.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 106.0108 | 2.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 109.9686 | 1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 110.1093 | 21.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 110.1098 | 7.79 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 112.9564 | 1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 113.0830 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 113.0840 | 4.38 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 114.1041 | 14.42 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 118.0781 | 18.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 119.0419 | 2.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 120.0017 | 0.56 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 120.0434 | 5.24 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 126.0418 | 2.72 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 129.0426 | 0.98 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 129.1519 | 4.77 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 130.0094 | 2.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 130.1108 | 0.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 132.0576 | 10.86 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 132.0707 | 3.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 132.0932 | 10.94 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 133.0182 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 133.1053 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 134.0722 | 16.33 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 134.0734 | 18.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 135.0679 | 1.33 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 136.0387 | 1.82 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 138.0540 | 5.24 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 142.0624 | 12.89 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 143.1303 | 13.29 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 145.1100 | 3.07 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 146.0502 | 4.42 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 146.0506 | 3.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | N-METHYL-ASPARTIC ACID (M+NA)+ | 147.0503 | 0.67 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells |
| AN001118 | 148.0154 | 20.67 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 148.0194 | 2.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 148.0521 | 18.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 148.0886 | 18.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 149.1029 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 150.1039 | 10.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 151.0217 | 0.67 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 152.1311 | 3.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 154.1187 | 0.7 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 156.0761 | 4.2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 156.0762 | 3.66 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 156.0763 | 3.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 157.1099 | 2.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 157.1463 | 15.11 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 159.0352 | 9.37 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 159.0352 | 12.54 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 159.0353 | 1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 159.0354 | 10.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 160.0782 | 3.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 161.0279 | 0.56 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 161.0513 | 1.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 162.0310 | 11.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 162.0681 | 20.38 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 162.1401 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 163.0485 | 1.84 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 164.0469 | 1.34 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 164.0471 | 1.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 164.0686 | 9.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 165.0455 | 2.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 165.0533 | 0.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 166.0601 | 17.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 166.0827 | 0.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 168.1142 | 10.96 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 169.0053 | 1.03 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 169.1107 | 7.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 170.0497 | 3.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 171.1620 | 17.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 172.0709 | 2.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 172.1465 | 14.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 173.0486 | 10.11 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 174.1407 | 16.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 175.0263 | 1.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 175.0638 | 12.55 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 175.0662 | 3.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 177.1136 | 0.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 178.0405 | 1.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 179.1019 | 5.44 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 179.1279 | 15.12 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 180.0228 | 1.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 180.0770 | 3.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 180.1520 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 181.0710 | 1.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 184.1079 | 9.84 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 184.9773 | 1.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 185.1046 | 2.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 185.2138 | 17.71 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 186.0991 | 1.09 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 187.0269 | 2.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 187.1214 | 7.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 188.0609 | 3.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 188.1143 | 1.1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 188.1162 | 2.04 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 188.1162 | 2.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 189.0840 | 6.03 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 189.0882 | 5.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 189.9567 | 1.01 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 190.0968 | 10.96 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 190.0972 | 10.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 190.1568 | 14.19 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 190.1569 | 14.42 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 191.1459 | 0.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 192.0586 | 14.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 192.1511 | 16.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 193.0833 | 5.48 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 193.1118 | 0.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 193.1432 | 17.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 194.0587 | 11.01 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 194.0942 | 17.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 194.1150 | 3.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 195.0965 | 5.25 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 196.1080 | 6.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 197.1417 | 12.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 197.1775 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 198.1618 | 21.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 198.1623 | 17.99 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 199.1569 | 12.47 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 199.1929 | 20.29 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 200.1523 | 7.16 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 201.0842 | 5.43 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 201.1722 | 0.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 201.1723 | 1.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 202.1316 | 2.89 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 203.0006 | 2.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 203.0976 | 9.38 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 203.1153 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 203.1159 | 8.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 204.0785 | 20.67 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 205.0462 | 0.84 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 205.0485 | 1.7 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | L-TRYPTOPHAN-15N2 [ISTD] (M+H)+ | 206.0844 | 3.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells |
| AN001118 | 206.0931 | 21.87 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 208.1074 | 10.94 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 208.1456 | 17.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 208.1532 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 209.0368 | 4.12 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 209.0426 | 1.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 209.0520 | 6.13 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 209.1028 | 7.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 209.1768 | 14.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 210.0793 | 1.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 210.1617 | 16.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 210.9719 | 1.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 210.9937 | 2.01 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 211.1118 | 6.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 212.1145 | 1.43 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 212.1392 | 14.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 212.1393 | 14.19 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 212.9736 | 1.27 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 213.2454 | 17.49 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 214.0892 | 3.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 214.0962 | 2.52 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 214.1311 | 1.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 214.9760 | 1.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 215.0625 | 5.48 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 215.1521 | 12.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 215.1885 | 14.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 216.0399 | 11.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 216.1470 | 2.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 216.9826 | 8.14 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 217.1137 | 12.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 217.1311 | 4.07 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 218.0122 | 1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 218.0187 | 0.68 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 218.0558 | 7.83 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 218.1265 | 2.64 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 219.1247 | 14.32 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 220.1257 | 8.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 221.0192 | 0.67 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 221.0220 | 0.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 221.1391 | 12.47 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 221.1744 | 22.88 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 221.1753 | 20.29 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 222.0855 | 10.77 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 222.1001 | 3.57 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 222.1012 | 2.99 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 222.1231 | 10.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 222.1234 | 10.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 222.1351 | 7.16 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 223.0149 | 0.7 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 223.1539 | 12.72 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 224.0780 | 1.78 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 225.0083 | 4.12 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 225.0092 | 4.51 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 225.0987 | 8.07 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 225.1345 | 7.83 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 225.1732 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 226.0044 | 1.03 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 226.2033 | 14.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 227.1880 | 22.88 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 227.1883 | 18.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 227.1890 | 16.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 227.2224 | 21.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 227.2604 | 17.22 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 228.0665 | 3.57 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 228.1047 | 14.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 228.1468 | 3.38 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 228.1474 | 3.2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 228.1475 | 4.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 228.1476 | 4.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 228.1816 | 11.52 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 229.1680 | 14.09 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 229.2404 | 17.42 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 229.2404 | 17.84 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 229.9930 | 1.7 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 230.1200 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 230.1631 | 3.49 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 230.1631 | 4.42 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 230.1635 | 4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 230.9792 | 1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 231.1297 | 14.75 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 232.0712 | 10.5 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 232.1429 | 0.56 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 232.1430 | 1.68 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 232.9745 | 0.99 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 233.1990 | 10.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 234.1614 | 19.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 235.0676 | 9.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 235.1542 | 14.37 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 236.1163 | 3.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 236.1163 | 3.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 236.1208 | 8.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 236.1488 | 9.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 236.2128 | 21.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 237.1048 | 18.24 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 237.1345 | 12.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 237.1700 | 14.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 238.0956 | 0.67 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 238.1355 | 8.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 238.1359 | 4.71 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 238.1424 | 22.01 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 238.1542 | 17.82 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 238.1544 | 17.98 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 238.2293 | 22.63 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 239.1879 | 17.19 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 239.1887 | 15.07 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 240.0628 | 8.07 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 240.0925 | 0.67 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 240.1466 | 1.54 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 240.1513 | 8.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 240.2092 | 21.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 241.2029 | 16.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 241.2036 | 17.5 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 241.2037 | 16.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 241.2042 | 22.88 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 241.2775 | 11.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 242.0822 | 18.24 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 242.1989 | 13.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 243.0861 | 0.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 243.0871 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 243.1463 | 4.07 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 243.1838 | 13.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 243.1838 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 243.1844 | 22.88 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 243.2555 | 17.84 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 243.2558 | 18.57 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 243.2562 | 18.12 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 244.0414 | 3.57 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 244.0727 | 14.87 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 244.1066 | 17.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 244.1795 | 6.59 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 244.1820 | 6.03 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 244.1878 | 5.29 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 245.1211 | 18.16 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 245.1453 | 16.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 245.1630 | 4.44 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 246.0870 | 2.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 246.1185 | 3.03 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 246.1221 | 2.32 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 247.1389 | 0.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 247.1405 | 1.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 247.1422 | 1.79 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 247.1436 | 16.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 248.1740 | 18.91 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 248.1743 | 18.66 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 248.1745 | 21.32 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 249.0863 | 2.83 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 249.1702 | 22.89 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 249.1707 | 16.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 249.2053 | 21.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 250.0981 | 9.82 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 250.1200 | 10.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 250.1521 | 0.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 250.1535 | 0.56 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 250.1655 | 11.52 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 251.0995 | 0.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 251.1206 | 19.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 251.1225 | 5.78 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 251.1267 | 5.29 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 251.1496 | 14.09 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 252.1121 | 3.42 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 252.2078 | 21 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 253.0768 | 18.24 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 253.1008 | 12.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 253.1278 | 2.92 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 253.1654 | 12.47 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 253.2043 | 18.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 253.2398 | 20.14 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 253.2407 | 2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 253.9915 | 1.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 254.1195 | 8.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 254.2242 | 22.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 254.2243 | 21.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 254.2254 | 21.29 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 254.2601 | 23.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 255.1365 | 19.23 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 255.1822 | 16.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 255.1831 | 15.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 255.1831 | 16.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 255.2190 | 20.87 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 255.2198 | 18.77 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 255.2562 | 22.51 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 256.1117 | 16.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 256.2152 | 15.07 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 257.0614 | 3.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 257.1201 | 1.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 257.1994 | 17.86 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 257.1996 | 17.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 257.2349 | 17.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 257.2710 | 19.88 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 257.2718 | 17.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 258.0804 | 5.08 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 258.1258 | 17.42 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 259.1607 | 18.43 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 260.0782 | 0.66 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 260.1039 | 14.38 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 260.1244 | 4.71 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 260.1355 | 3.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 260.1364 | 4.19 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 260.1368 | 4.47 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 260.1378 | 1.92 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 260.1833 | 16.92 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | HEXANOYLCARNITINE (*) M+ | 260.1865 | 7.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells |
| AN001118 | 261.0069 | 1.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 261.1044 | 7.08 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 261.1203 | 0.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 261.1210 | 1.04 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 261.1247 | 2.35 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 261.1574 | 2.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 261.1591 | 18.43 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 261.1704 | 17.2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 261.9781 | 1.24 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 262.1201 | 5.16 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 262.1352 | 4.49 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 262.1569 | 21.87 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 262.1648 | 12.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 263.1198 | 15.75 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 263.1501 | 12.16 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 263.1524 | 22.88 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 263.1637 | 3.71 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 263.1861 | 17.5 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 263.1863 | 16.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 263.2457 | 14.19 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 263.2462 | 14.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 264.1140 | 7.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 264.1159 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 264.1453 | 9.66 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 264.1482 | 4.99 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 264.1545 | 5.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 264.1818 | 13.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 264.9707 | 2.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 265.1358 | 16.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 265.1652 | 22.88 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 265.1658 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 265.1987 | 17.64 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 266.0355 | 4.52 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 266.0356 | 4.12 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 266.0955 | 2.37 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 266.1169 | 16.33 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 266.1266 | 3.87 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 266.1313 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 266.1370 | 1.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 266.1664 | 20.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 267.1809 | 14.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 267.1809 | 16.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 267.2182 | 18.49 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 268.2017 | 21.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 268.2194 | 22.64 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 268.2396 | 22.35 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 269.1307 | 14.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 269.1381 | 2.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 271.0211 | 1.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 271.1812 | 5.86 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 271.2149 | 18.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 271.2509 | 18.93 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 271.2514 | 17.24 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 271.2865 | 20.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 271.2865 | 20.42 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 272.0855 | 13.38 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 272.1031 | 16.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 272.1377 | 5.27 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 273.1762 | 19.84 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 273.1763 | 19.47 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 273.2666 | 17.56 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 273.2669 | 17.12 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 274.0002 | 1.27 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 274.0003 | 0.99 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 274.1100 | 14.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 274.1361 | 6.67 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 275.1194 | 9.32 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 275.1379 | 1.79 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 276.0545 | 0.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 276.0552 | 1.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 276.1346 | 14.7 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 276.1359 | 15.57 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 276.1737 | 19.48 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 277.1155 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 277.1157 | 0.8 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 277.2020 | 18.77 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 277.2380 | 22.51 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 277.2398 | 22.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 277.2405 | 22.13 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 277.2406 | 20.29 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 278.0323 | 10.68 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 278.0845 | 16.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 278.1534 | 20.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 278.1539 | 20.75 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 278.1633 | 6.93 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 278.1636 | 7.87 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 278.1641 | 7.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 278.1971 | 15.07 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 279.1317 | 0.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 279.1321 | 1.04 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 279.1511 | 21.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 279.1520 | 16.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 279.1814 | 17.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 279.1815 | 17.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 279.2563 | 22.37 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 280.1327 | 18.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 280.2039 | 21.59 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 280.2764 | 23.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 280.2768 | 23.72 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 281.1314 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 281.1973 | 16.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 281.2711 | 21.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 281.2723 | 20.64 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 282.1264 | 7.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 282.1266 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 282.1558 | 18.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 282.1712 | 5.87 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 282.2198 | 21.91 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 283.2137 | 18.84 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 283.2880 | 22.89 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 283.3228 | 21.22 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 284.0964 | 18.23 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 284.1390 | 7.32 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 284.1404 | 6.52 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 284.1414 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 284.1417 | 8.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 284.2098 | 11.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 284.2163 | 21.89 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 284.2351 | 21.35 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 284.2460 | 17.83 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 285.0169 | 1.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 285.0692 | 0.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 285.0845 | 1.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 285.1672 | 3.79 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 285.1688 | 2.7 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 285.2665 | 18.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 285.3032 | 19.27 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 285.3034 | 21.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 287.0572 | 0.78 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 287.0577 | 1.01 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 287.0605 | 8.87 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 287.1480 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 287.2459 | 21.22 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 287.2465 | 20.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 287.2513 | 17.68 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 287.2818 | 16.86 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 287.2820 | 18.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 287.2836 | 17.77 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 288.1478 | 20.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 288.1499 | 8.77 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 288.2398 | 15.75 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 288.2413 | 12.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 288.2773 | 14.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 289.1353 | 12.1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 289.1525 | 3.2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 289.2020 | 19.21 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 289.2021 | 18.49 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 289.2621 | 17.53 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 289.9757 | 1.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 290.0374 | 3.57 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 290.0824 | 14.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 290.1271 | 11.68 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 290.1883 | 19.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 291.0941 | 0.71 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 291.1154 | 2.79 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 292.0178 | 0.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 292.0861 | 5.37 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 292.1624 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 292.1634 | 0.89 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 292.1988 | 3.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 292.2011 | 21 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 292.2750 | 22.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 293.1483 | 1.79 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 293.1968 | 18.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 293.2327 | 19.98 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 293.2331 | 20.14 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 294.0909 | 5.92 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 294.1052 | 18.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 294.1225 | 2.8 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 294.1284 | 12.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 294.1583 | 4.34 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 294.1684 | 15.07 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 295.0541 | 0.7 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 295.1771 | 15.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 295.2125 | 18.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 296.0829 | 11.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 296.1051 | 18.23 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 296.1248 | 18.38 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 296.1258 | 5.78 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 296.1265 | 19.29 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 296.1419 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 296.2047 | 21.15 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 296.2328 | 22.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 296.2708 | 23.44 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 297.1032 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 297.1201 | 2.93 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 297.1808 | 16.03 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 297.2668 | 19.82 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 298.0852 | 1.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 298.0868 | 3.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 298.1046 | 12.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 298.1418 | 9.84 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 298.1572 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 298.9877 | 1.19 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 299.0889 | 4.47 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 299.1043 | 15.75 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 299.2240 | 22.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 299.2251 | 22.13 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 299.2789 | 21.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 299.2800 | 21.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 299.2831 | 20.64 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 300.1032 | 5.72 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 300.1339 | 20.57 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 300.1341 | 20.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 300.1371 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 300.1699 | 19.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 300.2778 | 16.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 300.9893 | 1.2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 301.0628 | 20.66 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 301.1140 | 1.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 301.1172 | 0.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 301.1876 | 2.77 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 301.1892 | 3.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 301.2080 | 21.77 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 301.2381 | 22.37 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 301.2618 | 17.24 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 301.2623 | 18.82 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 301.2980 | 21.08 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 301.3002 | 17.86 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 302.0310 | 2.54 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 302.0637 | 2.78 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 302.1525 | 8.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 302.1671 | 10.83 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 302.2561 | 15.75 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 302.2562 | 14.09 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 303.2775 | 18.33 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 303.2784 | 18.64 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 303.2919 | 18.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 303.2919 | 21.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 304.1539 | 5.86 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 304.1656 | 10.83 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 304.2405 | 22.71 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 304.2717 | 12.47 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 305.1963 | 18.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 305.2691 | 22.89 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 305.2696 | 22.57 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 306.0087 | 3.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 306.1067 | 7.79 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 306.1631 | 16.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 307.0840 | 1.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 307.1368 | 22.64 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 307.1581 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 307.2146 | 16.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 307.2485 | 20.97 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 307.2872 | 21.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 307.2877 | 22.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 308.1203 | 9.89 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 308.1206 | 10.1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 308.1253 | 15.43 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 308.1965 | 21.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 308.2071 | 14.93 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 308.2330 | 22.35 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 309.0862 | 1.01 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 309.1221 | 2.8 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 309.1621 | 18.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 309.2277 | 18.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 309.2281 | 21.22 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 309.2283 | 20.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 309.3019 | 21.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 309.3041 | 22.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 310.1193 | 10.1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 310.1199 | 2.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 310.1205 | 6.53 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 310.1215 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 310.1217 | 7.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 310.1722 | 21.8 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 310.1745 | 21.96 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 310.1783 | 17.14 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 310.2475 | 21.7 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 310.2590 | 17.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 311.1039 | 1.2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 311.1414 | 16.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 311.1879 | 18.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 311.2060 | 15.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 311.2415 | 17.53 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 311.2933 | 16.92 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 311.3190 | 23.2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 311.3545 | 21.86 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 312.0050 | 1.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 312.1368 | 20.67 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 312.2270 | 21.43 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 312.2662 | 22.55 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 312.2664 | 22.63 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 312.2664 | 26.14 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 312.2665 | 22.19 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 312.2766 | 17.2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 313.1017 | 1.21 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 313.1721 | 14.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 313.3345 | 20.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 314.0546 | 3.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 314.1160 | 18.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 314.1507 | 18.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 314.1676 | 21.92 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 314.1859 | 21.49 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 314.2562 | 12.16 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 314.2928 | 16.68 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 315.1300 | 1.72 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 315.2047 | 4.35 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 315.2142 | 5.2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 315.2169 | 19.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 315.2173 | 20.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 315.2179 | 20.15 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 315.2265 | 22.25 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 315.2875 | 13.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 315.3110 | 22.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 315.3117 | 20.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 315.3124 | 19.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 316.1678 | 17.5 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 316.1683 | 8.8 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 316.1826 | 12.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 316.2733 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 317.1527 | 6.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 317.1744 | 7.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 317.1747 | 8.43 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 317.2336 | 21.07 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 317.2340 | 20.3 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 317.2590 | 17.72 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 317.2913 | 20.44 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 317.2915 | 17.27 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 317.2932 | 16.78 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 318.1810 | 12.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 318.2866 | 14.41 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 318.2873 | 16.04 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 318.2882 | 22.35 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 318.2904 | 23.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 319.0843 | 1.35 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 319.1567 | 5.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 319.1768 | 15.91 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 320.0564 | 4.7 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 320.1240 | 9.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 320.1245 | 10.88 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 320.1778 | 16.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 320.3086 | 23.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 321.0950 | 10.25 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 321.1671 | 4.48 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 321.2292 | 18.04 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 321.2296 | 21.29 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 321.2638 | 22.63 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 321.2639 | 21.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 321.2651 | 20.64 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 321.3025 | 23.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 321.3039 | 22.91 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 322.0634 | 2.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 322.0852 | 5.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 322.0890 | 6.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 322.1307 | 3.65 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 322.1574 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 322.2190 | 23.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 322.2474 | 22.12 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 323.2103 | 16.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 323.2451 | 20.87 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 323.2798 | 21.08 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 323.3188 | 23.1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 324.1371 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 324.1474 | 3.63 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 324.1502 | 10.83 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 324.2280 | 22.08 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 324.2772 | 18.33 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 325.1158 | 1.43 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 325.2009 | 4.44 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 325.2960 | 22.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 325.2963 | 21.09 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 325.3340 | 23.38 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 325.3708 | 21.23 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 326.1168 | 6.24 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 326.2221 | 22.93 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 326.2409 | 21.97 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 326.3314 | 21.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 327.1146 | 16.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 327.1327 | 2.8 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 327.2175 | 6.98 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 327.2530 | 22.62 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 327.2799 | 22.15 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 327.3126 | 22.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 327.3171 | 21.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 328.1241 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 328.1322 | 7.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 328.1323 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 328.1329 | 6.52 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 328.1484 | 5.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 328.2363 | 23.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 328.2415 | 22.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 328.3097 | 18.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 329.0654 | 1.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 329.1150 | 16.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 329.1395 | 10.68 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 329.2396 | 22.5 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 329.2693 | 22.75 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 329.3045 | 15.07 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 329.3276 | 20.93 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 330.1019 | 10.09 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 330.1477 | 8.8 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 330.1821 | 19.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 330.1984 | 14.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 330.2778 | 22.63 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 330.2881 | 17.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 330.2882 | 17.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 331.1033 | 1.72 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 331.2859 | 22.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 331.3232 | 20.55 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 331.3239 | 20.21 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 331.3248 | 19.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 332.1616 | 17.14 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 332.1979 | 14.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 332.3041 | 16.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 333.0364 | 1.33 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 333.2878 | 19.72 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 333.2881 | 17.59 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 333.2970 | 22.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 333.3009 | 23.2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 333.3053 | 22.15 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 333.9711 | 1.01 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 334.0836 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 334.0992 | 12.54 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 334.1001 | 7.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 334.1184 | 20.66 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 334.2184 | 15.48 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 335.2149 | 22.86 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 335.3136 | 22.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 335.3192 | 23.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 335.3195 | 22.35 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 336.0958 | 9.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 336.0979 | 18.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 336.1002 | 12.54 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 336.1029 | 7.55 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 336.1189 | 10.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 336.1214 | 8.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 336.1493 | 21.93 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 336.1530 | 1.35 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 337.1338 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 337.2038 | 20.16 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 337.2581 | 19.36 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 337.2605 | 19.84 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 337.3325 | 22.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 337.3345 | 22.55 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 337.3348 | 22.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 337.3352 | 23.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 338.0560 | 5.71 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 338.1274 | 3.87 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 338.1288 | 15.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 338.1524 | 21.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 338.2690 | 10.44 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 339.2544 | 20.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 339.2746 | 17.27 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 339.3498 | 23.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 339.3839 | 22.23 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 340.1349 | 15.75 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 340.1719 | 15.07 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 340.2592 | 21.93 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 340.2605 | 22.32 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 340.2982 | 22.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 340.3094 | 18.49 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 341.1941 | 0.68 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 341.2321 | 8.68 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 341.2356 | 21.1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 341.3653 | 21.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 342.1269 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 342.1469 | 7.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 342.1477 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 342.1490 | 16.53 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 342.2069 | 18.57 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 342.2871 | 19.09 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 342.2882 | 15.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 342.3241 | 21.37 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 343.1272 | 1.43 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 343.1360 | 6.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 343.1868 | 0.66 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 343.2208 | 6.89 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 343.3431 | 23.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 344.1280 | 6.24 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 344.1396 | 19.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 344.1621 | 8.8 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 344.1798 | 21.03 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 344.2136 | 15.97 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 344.2141 | 14.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 344.3042 | 18.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 344.3383 | 2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 345.0394 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 345.3004 | 23.1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 346.1435 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 346.1792 | 14.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 346.2130 | 14.62 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 346.3194 | 18.6 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 347.0627 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 347.1429 | 7.62 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 347.2465 | 20.18 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 347.2646 | 22.96 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 347.2810 | 21.86 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 347.2853 | 22.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 347.3033 | 22.63 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 347.3197 | 17.35 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 347.9833 | 16.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 348.0511 | 19.63 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 348.1324 | 3.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 348.1574 | 8.8 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 348.1771 | 6.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 349.0950 | 2.11 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 349.1142 | 2.78 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 349.2028 | 20.25 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 349.2598 | 19.13 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 349.2611 | 22.15 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 349.2628 | 22.95 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 349.3338 | 21.51 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 349.3349 | 23.38 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 349.3353 | 23.2 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 349.9802 | 16.8 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 350.0894 | 0.98 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 350.0956 | 20.66 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 350.1270 | 3.7 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 350.1289 | 19.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 350.1643 | 21.96 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 350.2451 | 22.54 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 351.1771 | 16.25 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 351.2192 | 20.42 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 351.2411 | 20.57 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 351.2413 | 20.74 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 351.3122 | 21.9 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 351.3125 | 20.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 351.3135 | 22.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 351.3143 | 22.51 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 351.3461 | 23.44 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 352.0986 | 7.63 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 352.1102 | 10.03 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 352.1104 | 9.77 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 352.1144 | 21.92 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 352.1448 | 20.88 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 352.1804 | 14.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 352.2237 | 21.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 352.2600 | 22.63 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 352.3505 | 21.53 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 353.0881 | 2.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 353.1621 | 0.72 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 353.3036 | 17.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 353.3045 | 17.11 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 353.3273 | 22.56 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 353.3650 | 23.79 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 354.0568 | 11.22 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 354.0678 | 1.35 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 354.1098 | 10.04 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 354.1099 | 9.77 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 354.1790 | 14.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 355.1689 | 0.72 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 355.2856 | 22.92 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 355.2864 | 18.23 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 355.3419 | 22.55 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 355.3443 | 22.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 356.0579 | 11.22 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 356.0810 | 12.55 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 356.1405 | 22.12 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 356.1621 | 8.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 356.2364 | 0.72 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 356.2546 | 21.53 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 356.3038 | 18.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 357.1551 | 0.67 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 357.1617 | 19.68 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 357.1848 | 18.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 357.3018 | 23.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 357.3332 | 17.83 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 357.3601 | 21.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 358.0118 | 1.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 358.0813 | 12.55 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 358.1727 | 3.17 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 358.2295 | 17.34 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 358.3046 | 23.05 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 359.1948 | 4.27 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 359.2468 | 20.42 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 359.3081 | 21.69 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 359.3174 | 23.26 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 359.3554 | 21.22 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 359.3557 | 21.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 359.3567 | 21.42 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 360.1571 | 8.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 360.1730 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 360.1738 | 0.98 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 360.2083 | 14.32 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 360.2285 | 17.33 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 360.2688 | 22.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 360.3338 | 20.06 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 360.3345 | 18.76 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 361.1455 | 6.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 361.2964 | 22.92 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 361.3196 | 16.87 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 361.3323 | 23.58 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 361.3904 | 6.33 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 362.1731 | 8.8 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 362.3024 | 21.97 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 363.1162 | 7.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 363.1162 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 363.1691 | 8.39 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 363.2184 | 21.1 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 363.2189 | 21.43 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 363.3102 | 23.16 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 363.3481 | 22.66 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 364.1298 | 20.38 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 364.1302 | 19.97 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 364.2492 | 8.66 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 364.2713 | 19.09 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 364.3122 | 21.94 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 364.3156 | 23.88 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 365.0886 | 2.79 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 365.1098 | 1.47 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 365.1851 | 8.81 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 365.2896 | 20.85 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 365.2904 | 21.27 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 365.3661 | 23.63 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 366.1151 | 8.61 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 366.1256 | 13.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 366.1257 | 12.92 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 366.1259 | 12.44 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 366.1437 | 3.7 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 366.1527 | 0.71 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 366.1573 | 20.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 366.1604 | 20.14 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 366.1609 | 20.87 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 366.1610 | 21.02 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 366.1828 | 22.46 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 366.3242 | 20.32 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 367.3797 | 24.04 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 367.4180 | 22.44 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.1222 | 13.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.1244 | 7.31 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.1246 | 8.4 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.1251 | 6.53 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.1257 | 12.44 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.1258 | 12.92 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.1383 | 3.7 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.1449 | 14.45 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.1665 | 14.88 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.2144 | 5.28 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.2263 | 22.62 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.2877 | 22.78 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.3396 | 20.29 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 368.3767 | 21.89 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 369.0453 | 0.98 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells | |
| AN001118 | 369.0460 | 0.73 | Minutes | ST000714 | POSITIVE | Agilent 6530 QTOF | Reversed phase | Mouse | Tumor cells |